Capital Research Global Investors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $35.8M | Sell |
|
|||||
|
2021
Q3 | $303M | Sell |
|
|||||
|
2021
Q2 | $436M | Sell |
|
|||||
|
2021
Q1 | $840M | Buy |
|
|||||
|
2020
Q4 | $1.01B | Buy |
|
|||||
|
2020
Q3 | $558M | Buy |
|
|||||
|
2020
Q2 | $530M | Buy |
|
|||||
|
2020
Q1 | $292M | Buy |
|
|||||
|
2019
Q4 | $272M | Buy |
|
|||||
|
2019
Q3 | $272M | Buy |
|
|||||
|
2019
Q2 | $404M | Buy |
|
|||||
|
2019
Q1 | $441M | Buy |
|
|||||
|
2018
Q4 | $255M | Buy |
|
|||||
|
2018
Q3 | $447M | Buy |
|
|||||
|
2018
Q2 | $442M | Sell |
|
|||||
|
2018
Q1 | $302M | Buy |
|
|||||
|
2017
Q4 | $231M | Buy |
|
|||||
|
2017
Q3 | $218M | Sell |
|
|||||
|
2017
Q2 | $322M | Buy |
|
|||||
|
2017
Q1 | $346M | Buy |
|
|||||
|
2016
Q4 | $352M | Buy |
|
|||||
|
2016
Q3 | $343M | Buy |
|
|||||
|
2016
Q2 | $234M | Buy |
|
|||||
|
2016
Q1 | $302M | Buy |
|
|||||
|
2015
Q4 | $534M | Buy |
|
|||||
|
2015
Q3 | $456M | Buy |
|
|||||
|
2015
Q2 | $450M | Buy |
|
|||||
|
2015
Q1 | $265M | Buy |
|
|||||
|
2014
Q4 | $171M | Buy |
|
|||||
|
2014
Q3 | $217M | Buy |
|
|||||
|
2014
Q2 | $86.6M | Hold |
|
|||||
|
2014
Q1 | $89.9M | Buy |
|